L7 Informatics at World Vaccine & Immunotherapy Congress

Please join President & CEO Vasu Rangadass, Ph.D. for an in-depth look at the future of the lab and the digitalization of cell and gene therapy space. This session will also explore L7’s work with Gradalis, a late-stage biotechnology company focused on the development and commercialization of novel personalized therapeutics to treat cancer.